title: AJCC melanoma staging update: impact on dermatopathology practice and patient management.
abstract: Changes in the 2010 American Joint Commission on Cancer melanoma staging guidelines include the evaluation of primary tumor mitotic index (mitogenicity) and the recognized prognostic significance of a single melanoma cell in a sentinel lymph node. These revised criteria have important practice implications for dermatopathologists as well as for dermatologists, oncologists and surgeons who treat patients with cutaneous melanoma.
authors.affiliation: Dermatopathology Unit, Pathology Service, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
authors.forename: Adriano
authors.initials: A
authors.lastname: Piris
authors.forename: Martin C
authors.initials: MC
authors.lastname: Mihm
authors.forename: Lyn M
authors.initials: LM
authors.lastname: Duncan
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000473:pathology* / Q000628:therapy*; D009367:Neoplasm Staging / Q000379:methods*; D017410:Practice Guidelines as Topic; D021701:Sentinel Lymph Node Biopsy / Q000379:methods; D012878:Skin Neoplasms / Q000473:pathology* / Q000628:therapy*; D014481:United States